The majority of people in all except one of the 15 countries surveyed by Ipsos last week say they are self-isolating or quarantining at home to stop the spread of COVID-19.
In a survey of 28,000 people conducted from April 2 to 4, Japan is the only exception to this with just 15% of the respondents saying they are staying home to fight the coronavirus pandemic.
Countries in which at least four in five people now report they are self-isolating include Spain (95%), Vietnam (94%), France (90%), Brazil (89%), Mexico (88%), Russia (85%), the United States and India (84%). The peak for reported self-isolation was reached two weeks ago in about half the countries surveyed, and there has been little movement since.
However, respondents in a few countries have shown slight declines in self-isolation over the past week including China down 4 percentage points, India (-3), and Germany (-3). The country with the biggest increase in self-isolation is Russia (+23 points), followed by Vietnam (+16), Australia (+11), and Mexico (+8).
Overall, the data shows the strategy of self-isolation has become well-accepted by populations in most of the countries surveyed. Not only are governments implementing the measures, but their citizens are mostly complying and staying home.
These are the results of an Ipsos survey conducted April 2nd to 4th, 2020 on the Global Advisor online platform among 28,000 adults aged 18-74 in Canada and the United States and 16-74 in Australia, Brazil, China, France, Germany, Italy, India, Japan, Mexico, Russia, Vietnam and the United Kingdom. Where available, tracking results from previous studies, conducted through March and selected results from February are referenced by date.
Attitudes to COVID-19 vaccines [featured at the Davos Agenda 2021]
The global rollout of COVID-19 vaccines will be the largest, fastest and most challenging vaccination program in history. This could bring many problems. Some we will anticipate; some we won’t. One glaring problem that is quickly emerging is a major mismatch between vaccine supply and demand.